| Literature DB >> 32283888 |
Dursun Turkoz1, Cem Demirel1, Hüseyin Sataloğlu1, Cengiz Cokluk2.
Abstract
Background/aim: The aim of this study was to investigate the possible toxicity of the Ankaferd Blood Stopper (ABS) on the neural system. Materials and methods: Thirty Sprague Dawley rats were randomized into ABS (n: 15) and control (n: 15) groups. Following the anaesthetic induction, total laminectomy was performed to the lower thoracic, and upper lumbar areas in both groups and medulla spinalis was exposed. Two myelotomies were performed on the medulla spinalis. One millilitre ABS was applied to the incision site in the ABS group, and one millilitre 0.9% saline solution was applied in the control group. Rats were observed for 15 days regarding general behaviour, neurological signs, mobility, and signs of infection. Sixteen days later, all rats were decapitated under anaesthesia. Medulla spinalis was removed en bloc from all rats and was stained with Heamatoxylin & Eosin and luxol fast blue.Entities:
Keywords: Ankaferd Blood Stopper; haemostasis; spinal cord
Year: 2020 PMID: 32283888 PMCID: PMC7379454 DOI: 10.3906/sag-2001-249
Source DB: PubMed Journal: Turk J Med Sci ISSN: 1300-0144 Impact factor: 0.973
Histopathological findings in ABS group.
| Rats | Neuron count | Oedema | Gliosis, reactive astrocytoma | Neuronal degeneration | Inflammatorycell | Myelin degeneration |
|---|---|---|---|---|---|---|
| ABS1 | 11 | 0 | 0 | 1 | 0 | 0 |
| ABS2 | 10 | 0 | 1 | 0 | 1 | 0 |
| ABS3 | 5 | 0 | 0 | 1 | 1 | 0 |
| ABS4 | 12 | 0 | 0 | 0 | 0 | 0 |
| ABS5 | 11 | 0 | 0 | 0 | 0 | 0 |
| ABS6 | 9 | 0 | 0 | 0 | 0 | 0 |
| ABS7 | 14 | 0 | 0 | 0 | 0 | 0 |
| ABS8 | 11 | 1 | 0 | 0 | 0 | 0 |
| ABS9 | 9 | 1 | 0 | 1 | 2 | 0 |
| ABS10 | 3 | 1 | 0 | 0 | 1 | 1 |
| ABS11 | 6 | 1 | 1 | 0 | 0 | 0 |
| ABS12 | 7 | 1 | 0 | 1 | 2 | 0 |
| ABS13 | 13 | 0 | 0 | 0 | 0 | 0 |
| ABS14 | 11 | 1 | 1 | 0 | 0 | 0 |
| ABS15 | 13 | 0 | 0 | 0 | 0 | 0 |
Histopathological findings in control group.
| Rats | Neuron count | Oedema | Gliosis, reactive astrocytoma | Neuronal degeneration | Inflammatory cell | Myelin degeneration |
|---|---|---|---|---|---|---|
| Control1 | 13 | 0 | 0 | 0 | 0 | 0 |
| Control2 | 9 | 1 | 1 | 0 | 0 | 1 |
| Control3 | 14 | 1 | 0 | 0 | 0 | 0 |
| Control4 | 9 | 0 | 0 | 0 | 0 | 0 |
| Control5 | 7 | 1 | 0 | 1 | 2 | 0 |
| Control6 | 11 | 1 | 0 | 0 | 1 | 0 |
| Control7 | 6 | 1 | 0 | 1 | 1 | 0 |
| Control8 | 4 | 1 | 0 | 0 | 1 | 0 |
| Control9 | 22 | 1 | 0 | 0 | 1 | 0 |
| Control10 | 19 | 0 | 0 | 0 | 1 | 0 |
| Control11 | 16 | 0 | 0 | 0 | 0 | 0 |
| Control12 | 14 | 0 | 0 | 0 | 1 | 0 |
| Control13 | 14 | 0 | 0 | 0 | 1 | 0 |
| Control14 | 4 | 1 | 0 | 1 | 1 | 0 |
| Control15 | 6 | 0 | 0 | 0 | 0 | 0 |
Comparison of 2 groups.
| Control | ABS | P | |||||
|---|---|---|---|---|---|---|---|
| None | Mild | Severe | None | Mild | Severe | ||
| Oedema | 7 | 8 | - | 7 | 8 | - | P > 0.05 |
| Gliosis, reactive astrocytoma | 12 | 3 | - | 14 | 1 | - | P > 0.05 |
| Neuronal degeneration | 11 | 4 | - | 12 | 3 | - | P > 0.05 |
| Inflammatory cell | 10 | 3 | 2 | 6 | 8 | 1 | P > 0.05 |
| Myelin degeneration | 14 | 1 | - | 14 | 1 | - | P > 0.05 |